Enhanced Immunotherapy for Glioblastoma Using a Cholesterol Oxidase-Loaded, Pd-Doped Cu <sub>3</sub> N Nanozyme-Based Multimodal Nanoplatform
PdN@CR significantly suppresses tumor growth and prolongs survival without systemic toxicity. Collectively, this study establishes a BBB-permeable, US-augmented nanoplatform as a promising ferroptosis/cuproptosis-based strategy for effective GBM therapy.
Authors
- Songsong Xia
- D Chen
- G N Wang
- Zi Zhu
- Songyu Yang
- Man Guo
- Chenghao Yu
- Lili Feng
Institutions
- Harbin Engineering University (CN)
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- ACS Nano
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1021/acsnano.6c00714
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
- Natural Science Foundation of Heilongjiang Province
- Fundamental Research Funds for the Central Universities